ArticleCancer gene therapy2024

Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model.

Fei Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.